Health authorities in Guinea declared an outbreak of Ebola in the rural community of Gouéké in N’Zerekore prefecture after three Ebola cases were confirmed by the national laboratory, marking…
The four leading international health and humanitarian organizations announced the establishment of a global Ebola vaccine stockpile to ensure outbreak response. The effort to establish…
The VSV-EBOPLUS scientist Helder Nakaya has been recognized as one of the Highly Cited Researchers 2020 and as a true pioneer in the field of…
Due to the COVID-19 crisis, the VSV-EBOPLUS Project meeting 2020 was held as online meeting on 21st and 22nd September 2020. Representatives of each Institution…
Due to the COVID-19 crisis, the planned VSV-EBOPLUS Project meeting in Camogli (Genova, Italy) has been canceled. Therefore, a virtual project meeting is scheduled on…
The U.S. Food and Drug Administration announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused…
The World Health Organization (WHO) today prequalified an Ebola vaccine for the first time, a critical step that will help speed up its licensing, access…
EMA’s human medicines committee (CHMP) has recommended granting a conditional marketing authorisation in the European Union for Ervebo (rVSVΔG-ZEBOV-GP), the first vaccine for active immunisation…
Today, the European Commission adopted the decision granting marketing authorisation to the company Merck Sharp & Dohme B.V. for a vaccine against Ebola. This vaccine,…